UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Questcor Pharmaceuticals

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

In a report published Wednesday, Jefferies & Company reiterated its Buy rating on Questcor Pharmaceuticals (NASDAQ: QCOR), and raised its price target from $28.00 to $30.00.Jefferies noted, “QCOR beat Q3 revenue and GAAP EPS consensus driven by higher Acthar sales and lower OpEx. Curiously, mgmt has decided to end its monthly disclosure of Acthar Rx citing sales have reached a ‘mature' level, however, mgmt will allow pharmacy distributors to release Rx data to third party providers. We are raising our PT to $30 on lower OpEx and share count, offset by a slight decrease in Acthar sales.”Questcor Pharmaceuticals closed on Tuesday at $25.93.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!